362 related articles for article (PubMed ID: 22102611)
1. Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.
Sarrio D; Franklin CK; Mackay A; Reis-Filho JS; Isacke CM
Stem Cells; 2012 Feb; 30(2):292-303. PubMed ID: 22102611
[TBL] [Abstract][Full Text] [Related]
2. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
Morel AP; Hinkal GW; Thomas C; Fauvet F; Courtois-Cox S; Wierinckx A; Devouassoux-Shisheboran M; Treilleux I; Tissier A; Gras B; Pourchet J; Puisieux I; Browne GJ; Spicer DB; Lachuer J; Ansieau S; Puisieux A
PLoS Genet; 2012; 8(5):e1002723. PubMed ID: 22654675
[TBL] [Abstract][Full Text] [Related]
3. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.
Prat A; Karginova O; Parker JS; Fan C; He X; Bixby L; Harrell JC; Roman E; Adamo B; Troester M; Perou CM
Breast Cancer Res Treat; 2013 Nov; 142(2):237-55. PubMed ID: 24162158
[TBL] [Abstract][Full Text] [Related]
4. Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.
Bakiri L; Macho-Maschler S; Custic I; Niemiec J; Guío-Carrión A; Hasenfuss SC; Eger A; Müller M; Beug H; Wagner EF
Cell Death Differ; 2015 Feb; 22(2):336-50. PubMed ID: 25301070
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.
Celià-Terrassa T; Meca-Cortés O; Mateo F; Martínez de Paz A; Rubio N; Arnal-Estapé A; Ell BJ; Bermudo R; Díaz A; Guerra-Rebollo M; Lozano JJ; Estarás C; Ulloa C; Álvarez-Simón D; Milà J; Vilella R; Paciucci R; Martínez-Balbás M; de Herreros AG; Gomis RR; Kang Y; Blanco J; Fernández PL; Thomson TM
J Clin Invest; 2012 May; 122(5):1849-68. PubMed ID: 22505459
[TBL] [Abstract][Full Text] [Related]
6. Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells.
Kumar A; Xu J; Sung B; Kumar S; Yu D; Aggarwal BB; Mehta K
Breast Cancer Res; 2012 Jan; 14(1):R4. PubMed ID: 22225906
[TBL] [Abstract][Full Text] [Related]
7. Claudin-7 promotes the epithelial-mesenchymal transition in human colorectal cancer.
Philip R; Heiler S; Mu W; Büchler MW; Zöller M; Thuma F
Oncotarget; 2015 Feb; 6(4):2046-63. PubMed ID: 25514462
[TBL] [Abstract][Full Text] [Related]
8. Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability.
Guo C; Liu H; Zhang BH; Cadaneanu RM; Mayle AM; Garraway IP
PLoS One; 2012; 7(4):e34219. PubMed ID: 22514625
[TBL] [Abstract][Full Text] [Related]
9. CDKL2 promotes epithelial-mesenchymal transition and breast cancer progression.
Li L; Liu C; Amato RJ; Chang JT; Du G; Li W
Oncotarget; 2014 Nov; 5(21):10840-53. PubMed ID: 25333262
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory factors of the tumor microenvironment induce plasticity in nontransformed breast epithelial cells: EMT, invasion, and collapse of normally organized breast textures.
Leibovich-Rivkin T; Liubomirski Y; Bernstein B; Meshel T; Ben-Baruch A
Neoplasia; 2013 Dec; 15(12):1330-46. PubMed ID: 24403855
[TBL] [Abstract][Full Text] [Related]
11. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines.
Keller PJ; Lin AF; Arendt LM; Klebba I; Jones AD; Rudnick JA; DiMeo TA; Gilmore H; Jefferson DM; Graham RA; Naber SP; Schnitt S; Kuperwasser C
Breast Cancer Res; 2010; 12(5):R87. PubMed ID: 20964822
[TBL] [Abstract][Full Text] [Related]
12. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
13. Transient but not stable ZEB1 knockdown dramatically inhibits growth of malignant pleural mesothelioma cells.
Horio M; Sato M; Takeyama Y; Elshazley M; Yamashita R; Hase T; Yoshida K; Usami N; Yokoi K; Sekido Y; Kondo M; Toyokuni S; Gazdar AF; Minna JD; Hasegawa Y
Ann Surg Oncol; 2012 Jul; 19 Suppl 3(Suppl 3):S634-45. PubMed ID: 22086445
[TBL] [Abstract][Full Text] [Related]
14. Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells.
Gauck D; Keil S; Niggemann B; Zänker KS; Dittmar T
BMC Cancer; 2017 Aug; 17(1):515. PubMed ID: 28768501
[TBL] [Abstract][Full Text] [Related]
15. Normal Breast-Derived Epithelial Cells with Luminal and Intrinsic Subtype-Enriched Gene Expression Document Interindividual Differences in Their Differentiation Cascade.
Kumar B; Prasad M; Bhat-Nakshatri P; Anjanappa M; Kalra M; Marino N; Storniolo AM; Rao X; Liu S; Wan J; Liu Y; Nakshatri H
Cancer Res; 2018 Sep; 78(17):5107-5123. PubMed ID: 29997232
[TBL] [Abstract][Full Text] [Related]
16. ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.
Thomas C; Rajapaksa G; Nikolos F; Hao R; Katchy A; McCollum CW; Bondesson M; Quinlan P; Thompson A; Krishnamurthy S; Esteva FJ; Gustafsson JÅ
Breast Cancer Res; 2012 Nov; 14(6):R148. PubMed ID: 23158001
[TBL] [Abstract][Full Text] [Related]
17. EpCAM expression in breast cancer cells is associated with enhanced bone metastasis formation.
Hiraga T; Ito S; Nakamura H
Int J Cancer; 2016 Apr; 138(7):1698-708. PubMed ID: 26576938
[TBL] [Abstract][Full Text] [Related]
18. Dual TGFβ/BMP Pathway Inhibition Enables Expansion and Characterization of Multiple Epithelial Cell Types of the Normal and Cancerous Breast.
Prasad M; Kumar B; Bhat-Nakshatri P; Anjanappa M; Sandusky G; Miller KD; Storniolo AM; Nakshatri H
Mol Cancer Res; 2019 Jul; 17(7):1556-1570. PubMed ID: 30992305
[TBL] [Abstract][Full Text] [Related]
19. A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression.
Yu M; Smolen GA; Zhang J; Wittner B; Schott BJ; Brachtel E; Ramaswamy S; Maheswaran S; Haber DA
Genes Dev; 2009 Aug; 23(15):1737-42. PubMed ID: 19651985
[TBL] [Abstract][Full Text] [Related]
20. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
